Body mass index as a possible predictor of the development of endocrine immune-mediated adverse events during immune checkpoint inhibitors therapy

Body mass index as a possible predictor of the development of endocrine immune-mediated adverse events during immune checkpoint inhibitors therapy

BACKGROUND: Overweight and obesity have a significant impact on the course and results of treatment of many diseases, including cancer. One of the modern types of antitumor therapy is immune checkpoint inhibitors. Taking into account the high effectiveness of immune checkpoint inhibitors for various...

Descripción completa

Detalles Bibliográficos
Autores principales: A. A. Glibka, N. V. Mazurina, E. A. Troshina, K. A. Sarantseva, G. Yu. Kharkevich, M. V. Volkonskii, A. R. Elfimova
Formato: Artículo
Lenguaje:English
Publicado: Endocrinology Research Centre 2024-04-01
Colección:Ожирение и метаболизм
Materias:
immune checkpoint inhibitors
immune-mediated adverse events
body mass index
destructive thyroiditis
hypophysitis
diabetes mellitus
Acceso en línea:https://www.omet-endojournals.ru/jour/article/view/13044

Ejemplares similares

Ejemplares similares